Gel Documentation Systems Market size is set to grow by USD 52.21 million from 2023-2027, Increase in use of molecular biology techniques in clinical practice boost the market, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ -- The global gel documentation systems market size is estimated to grow by USD 52.21 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of about 3.58% during the forecast period. Increase in use of molecular biology techniques in clinical practice is driving market growth, with a trend towards rising costs of clinical trials. However, lack of efficiency and effectiveness compared to conventional methods poses a challenge. Key market players include ATTO Corporation, Azure Biosystems Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Carestream Health Inc, Cleaver Scientific Ltd., Clinx Science Instruments Co. Ltd., Corning Inc., Endress Hauser Group Services AG, Gel Co. Inc, General Electric Co., GOLD SIM International Group Co. Ltd., Isogen Life Science BV, LI COR Inc., Royal Bio Tech, SDI Group plc, Thermo Fisher Scientific Inc., Vilber Lourmat, VWR International LLC, and Wealtec Corp..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Gel Documentation Systems Market Scope
Report Coverage
Details
Base year 2022
Historic period
2017 - 2021
Forecast period
2023-2027
Growth momentum & CAGR Accelerate at a CAGR of 3.58%
Market growth 2023-2027
USD 52.21 million
Market structure
Fragmented
YoY growth 2022-2023 (%) 2.5
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution North America at 37%
Key countries
US, Canada, UK, Germany, and China
Key companies profiled ATTO Corporation, Azure Biosystems Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Carestream Health Inc, Cleaver Scientific Ltd., Clinx Science Instruments Co. Ltd., Corning Inc.,
Endress Hauser Group Services AG, Gel Co. Inc, General Electric Co., GOLD SIM International Group Co. Ltd., Isogen Life Science BV, LI COR Inc., Royal Bio Tech, SDI Group plc, Thermo
Fisher Scientific Inc., Vilber Lourmat, VWR International LLC, and Wealtec Corp.
Market Driver
The clinical trials process for bringing new drugs to market is a complex and costly endeavor for pharmaceutical companies. With increasing regulations requiring more clinical data and longer safety testing periods, clinical trials for chronic disease treatments can be particularly expensive, often costing between USD300-350 million per drug from the clinical stage to commercialization. However, with multiple projects in development, the overall cost can reach USD3-5 billion. One of the major challenges in clinical trials is patient recruitment and retention, with approximately 45-50% of trials in the US delayed due to these issues. To address this, companies must focus on patient education and awareness, rather than persuasion, to encourage willing participation. This patient-centric approach could help resolve recruitment and continuation issues, leading to a more efficient clinical trials process. As the clinical research industry continues to grow, the need for analytical instruments like gel documentation systems will also increase, making them a valuable investment for clinical research labs, hospitals, and diagnostic centers.
Gel documentation systems have gained significant traction in various industries, including hospitals, diagnostic laboratories, pharmaceutical and biotechnology corporations. These systems are essential for imaging and recording results from agarose and acrylamide gels used in molecular biology. They find extensive applications in nucleic acid and protein research, with technologies like ethidium bromide, fluorophores (SYBR Green), protein quantification, immunoassays, 2D electrophoresis, and nucleic acid quantification. Gel documentation systems are crucial in identifying infectious diseases and genetic disorders. They employ digital systems, ultraviolet, chemiluminescence, and fluorescence techniques for imaging. Accessories and software enhance their functionality, while computer vision techniques enable biomedical movies and microscopy. Neutrophils immune cells, cardiovascular disease, cancer research, and treatment of diseases are some areas benefiting from these advanced systems. Gel documentation systems contribute significantly to molecular biology, enabling precise analysis of DNA, RNA, and proteins.
Discover 360° analysis of this market. For complete information, schedule your consultation - Book Here!
Market Challenges
-- Molecular diagnostics, while offering advantages, cannot fully replace
conventional diagnostic methods for infectious diseases due to the
efficiency and affordability of current clinical microbiology
techniques. Rapid antigen tests and automated culture systems have
advanced, enabling quicker identification and susceptibility testing.
However, limitations exist with molecular techniques, such as false
positives and negatives. To mitigate these issues, specialized
laboratories with trained staff and adequate space are necessary.
Improper primer design and contaminants inhibiting enzyme activity can
also lead to inaccurate results. Negative controls, such as ultraviolet
light irradiation and chemical inactivation, are essential to prevent
incorrect outcomes. Despite advancements, inexpensive and simple
microarray technologies are not yet available to address the issue of
detecting organisms with unknown sequences.
-- Gel documentation systems are essential tools in various industries,
particularly in molecular biology labs, for analyzing nucleic acids and
proteins. These systems facilitate the visualization and documentation
of gel images, which are crucial in fields like nucleic acid
quantification, infectious diseases, and genetic disorders. Challenges
in this market include the need for accurate quantification of nucleic
acids, identification of infectious diseases, and detection of genetic
disorders. Accessories, software, and techniques like ultraviolet,
chemiluminescence, and fluorescence are used to address these
challenges. Gel documentation systems support various types of gels,
including Agarose and Acrylamide, and employ digital systems for
improved gel imaging. They are used in molecular biology for DNA
separation, sequencing, preparation, and labeling. Technologies like
computer vision techniques, biomedical movies, and microscopy aid in the
analysis of cells, such as neutrophils immune cells, and the study of
cardiovascular disease. All-in-one gel documentation systems cater to
the needs of researchers and diagnostics, providing advanced features
for handling various gel types and analysis techniques. These systems
are integral to the treatment of diseases like cancer, and the
development of sequencing technologies.
For more insights on driver and challenges - Request a sample report!
Segment Overview
This gel documentation systems market report extensively covers market segmentation by
1. Product
-- 1.1 Instruments
-- 1.2 Software
-- 1.3 Accessories
2. End-user
-- 2.1 Hospitals and diagnostic centers
-- 2.2 Pharma and biotech companies
-- 2.3 Academic and research institutes
3. Geography
-- 3.1 North America
-- 3.2 Europe
-- 3.3 Asia
-- 3.4 Rest of World (ROW)
1.1 Instruments- The Gel Documentation Systems market refers to the industry that provides solutions for creating, managing, and publishing technical documentation. These systems help businesses streamline their documentation process, ensuring accurate and up-to-date information for their customers and internal teams. Features include version control, easy authoring, and integration with other business tools. Companies benefit from improved efficiency, reduced errors, and enhanced customer support.
For more information on market segmentation with geographical analysis including forecast (2023-2027) and historic data (2017-2021) - Download a Sample Report
Research Analysis
Gel documentation systems are advanced instruments used in various fields of life sciences, including molecular biology, hospitals, diagnostic laboratories, pharmaceutical corporations, and biotechnology corporations. These systems enable the imaging and recording of gels, such as agarose and acrylamide gels, used in the analysis of nucleic acids, proteins, and other biological materials. Imaging and recording are accomplished using techniques like ethidium bromide staining, fluorophores such as SYBR Green, and computer vision techniques. Biomedical movies and microscopy are often employed to observe cells and immune cells, such as neutrophils, in real-time. Gel documentation systems are essential tools for protein quantification and the analysis of cardiovascular disease, among other applications. They offer digital systems that enhance the accuracy and efficiency of gel imaging, making them indispensable in modern laboratories. Gel documentation systems are used extensively in molecular biology research, particularly in the analysis of nucleic acids and proteins. These systems facilitate the visualization and quantification of biomolecules, enabling researchers to gain valuable insights into biological processes and develop new therapeutics.
Market Research Overview
Gel documentation systems are advanced instruments used for imaging and recording results from various gel-based experiments in the fields of molecular biology, diagnostics, and research. These systems are employed in hospitals, diagnostic laboratories, pharmaceutical corporations, and biotechnology corporations for the analysis of nucleic acids, proteins, and other biomolecules. Agarose gels, acrylamide gels, and other types of gels are used in these systems for separation, sequencing, preparation, and labeling of nucleic acids. Ethidium bromide, fluorophores such as SYBR Green, and other staining methods are used for visualization. Gel documentation systems utilize digital systems, computer vision techniques, ultraviolet, chemiluminescence, and fluorescence for imaging and analysis. Applications include nucleic acid and protein quantification, immunoassays, 2D electrophoresis, infectious diseases, genetic disorders, and cancer research. Accessories and software are also available for these systems, along with microscopy, biomedical movies, and cell analysis. Gel image systems and gel imagers are essential tools in molecular biology labs for the treatment of diseases and advancements in sequencing technologies. Deoxyribonucleic acid (DNA) and other nucleic acids are prepared and separated using these systems, with labeling and staining methods such as Coomassie Brilliant Blue, silver staining, and all-in-one systems. Cellulose, agarose, acrylamide, and other materials are used in the preparation of gels. Gel documentation systems are integral to the advancement of research and diagnostics in various fields.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
-- Product
-- Instruments
-- Software
-- Accessories
-- End-user
-- Hospitals And Diagnostic Centers
-- Pharma And Biotech Companies
-- Academic And Research Institutes
-- Geography
-- North America
-- Europe
-- Asia
-- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/gel-documentation-systems-market-size-is-set-to-grow-by-usd-52-21-million-from-2023-2027--increase-in-use-of-molecular-biology-techniques-in-clinical-practice-boost-the-market-technavio-302209595.html
SOURCE Technavio
